Literature DB >> 9143810

Abnormalities of the extracellular matrix in keratoconus corneas.

M C Kenney1, A B Nesburn, R E Burgeson, R J Butkowski, A V Ljubimov.   

Abstract

PURPOSE: To study alterations of the extracellular matrix (ECM) and basement membrane (BM) components in human keratoconus corneas.
METHODS: Fifteen normal and 13 keratoconus corneas were characterized by immunofluorescence with antibodies to 23 ECM and BM components.
RESULTS: Keratoconus staining patterns for posterior nonscarred regions and Descemet's membrane were normal. We focused on three areas of keratoconus corneas: (a) nonscarred anterior corneal regions, (b) scarred anterior and posterior corneal regions, and (c) gaps in Bowman's layer. In each of these areas, consistent ECM and BM changes could be found. Nonscarred regions showed decreased staining of the epithelial BM for entactin/nidogen, fibronectin, alpha 3-alpha 5 chains of type IV collagen, and chains of laminin-1. In contrast, scarred regions had greater than normal staining of the epithelial BM for these same components and also for laminin-5, perlecan, and type VII collagen. In the Bowman's layer gaps/breaks, focal fibrotic deposits containing type VIII collagen, fibrillin-1, tenascin-C, alpha 1-alpha 2 type IV collagen, and normal stromal ECM and epithelial BM components were seen. Fibrotic regions were largely restricted to areas where, because of the lack of Bowman's layer, the epithelium was in contact with the stroma.
CONCLUSIONS: In a single keratoconus cornea, abnormalities in the ECM/BM patterns were not uniform. This may reflect locally increased protease activity (where few if any BM components are found) and ongoing wound healing (where more BM or ECM components or both are found).

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9143810

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  60 in total

1.  [The extracellular matrix structure in keratoconus].

Authors:  O Stachs; A Bochert; T Gerber; D Koczan; H J Thiessen; R F Guthoff
Journal:  Ophthalmologe       Date:  2004-04       Impact factor: 1.059

2.  Atopic rhinitis: a risk factor for spontaneous wound dehiscence following removal of a continuous penetrating keratoplasty suture.

Authors:  Hari Jayaram; Michael G Falcon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-03-11       Impact factor: 3.117

3.  Quantified histopathology of the keratoconic cornea.

Authors:  Jessica H Mathew; John D Goosey; Jan P G Bergmanson
Journal:  Optom Vis Sci       Date:  2011-08       Impact factor: 1.973

4.  Changes in tear protein profile in keratoconus disease.

Authors:  A Acera; E Vecino; I Rodríguez-Agirretxe; K Aloria; J M Arizmendi; C Morales; J A Durán
Journal:  Eye (Lond)       Date:  2011-06-24       Impact factor: 3.775

5.  Polymorphisms in COL4A3 and COL4A4 genes associated with keratoconus.

Authors:  Mirna Stabuc-Silih; Metka Ravnik-Glavac; Damjan Glavac; Marko Hawlina; Mojca Strazisar
Journal:  Mol Vis       Date:  2009-12-20       Impact factor: 2.367

Review 6.  Injury and defective regeneration of the epithelial basement membrane in corneal fibrosis: A paradigm for fibrosis in other organs?

Authors:  Steven E Wilson; Gustavo K Marino; Andre A M Torricelli; Carla S Medeiros
Journal:  Matrix Biol       Date:  2017-06-15       Impact factor: 11.583

7.  Wounded embryonic corneas exhibit nonfibrotic regeneration and complete innervation.

Authors:  James W Spurlin; Peter Y Lwigale
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-09-24       Impact factor: 4.799

8.  Riboflavin-Ultraviolet A Corneal Cross-linking for Keratoconus.

Authors:  Tamer M El-Raggal
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

9.  Keratoconus: overview and update on treatment.

Authors:  Ladan Espandar; Jay Meyer
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

10.  Sequence variants in COL4A1 and COL4A2 genes in Ecuadorian families with keratoconus.

Authors:  Justyna A Karolak; Karolina Kulinska; Dorota M Nowak; Jose A Pitarque; Andrea Molinari; Malgorzata Rydzanicz; Bassem A Bejjani; Marzena Gajecka
Journal:  Mol Vis       Date:  2011-03-30       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.